Antibacterial prophylaxis with lactoferrin in neutropenic patients

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
U TrümplerA Rosenmund

Abstract

The prevention of enterogenic infection by human lactoferrin was tested in five neutropenic patients receiving chemotherapy for acute myelogenous leukemia. Lactoferrin did not significantly delay the onset of infection but reduced its duration and severity as judged from the course of fever. Compared with nine matched controls, lactoferrin-treated patients had a lower incidence of bacteremia on the whole and of gram-negative bacteremia in particular.

References

Apr 1, 1978·Journal of Clinical Pathology·D Y Mason, C R Taylor
Feb 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L S Young
Dec 23, 1968·Biochimica Et Biophysica Acta·J D Oram, B Reiter
Mar 1, 1970·The Journal of Experimental Medicine·M BaggioliniJ F Heremans
Jan 1, 1984·The International Journal of Biochemistry·J StuartJ P Harrington
Jan 14, 1980·FEBS Letters·L Bläckberg, O Hernell

❮ Previous
Next ❯

Citations

Oct 18, 2001·Journal of the American College of Nutrition·O M Conneely
Dec 19, 2008·Critical Reviews in Food Science and Nutrition·Lígia RodriguesHelena Lindmark Månsson
Dec 22, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L H Vorland
Aug 29, 2006·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Koji YamauchiMitsunori Takase
Jun 3, 1999·Clinical Chemistry and Laboratory Medicine : CCLM·S BaveyeD Legrand
Feb 19, 2010·Animal Science Journal = Nihon Chikusan Gakkaihō·Shiro KushibikiKoichi Hodate
Jul 4, 2007·Transplant Infectious Disease : an Official Journal of the Transplantation Society·W J F M van der VeldenJ P Donnelly
Mar 21, 2008·Transplant Infectious Disease : an Official Journal of the Transplantation Society·T J GuttebergH H Hirsch
Oct 30, 2016·Critical Reviews in Food Science and Nutrition·Dominique Bouglé, Saïd Bouhallab
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Mohan Pammi, Steven A Abrams
May 12, 2019·The Cochrane Database of Systematic Reviews·Mohan Pammi, Steven A Abrams
Jun 3, 2009·Expert Review of Anti-infective Therapy·Mohan Venkatesh, Steven Abrams
Jul 25, 2013·Expert Review of Anti-infective Therapy·Krithika LingappanMohan Pammi
Dec 4, 2019·Expert Review of Clinical Pharmacology·Susanna Esposito, Nicola Principi
Jun 29, 2017·The Cochrane Database of Systematic Reviews·Mohan Pammi, Gautham Suresh
Apr 2, 2020·The Cochrane Database of Systematic Reviews·Mohan Pammi, Gautham Suresh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.